Clever Culture Systems has raised $1.8M in new funding. The Australian microbiology company, listed on the ASX as CC5, uses artificial intelligence to automate the reading of culture plates in hospital and diagnostic labs.
Its flagship instrument, the APAS Independence, screens and sorts plates at up to 200 per hour, flagging negative plates so microbiologists can concentrate on the positive ones that need their attention. The company says the platform is the only FDA-cleared instrument using AI in microbiology, and it offers modules for urine, infection control, respiratory and MRSA testing.













